Samsung Electronics
CompanySouth Korea
Samsung Electronics develops one asset, in human trials (Bot-Fit in type 2 diabetes). Mostly device; based in South Korea.
- 1
- Asset
- Furthest stage
- Human trials
- 2
- Grants
- 0
- Trials
- 0
- Signals
Pipeline
1Wearable hip exoskeleton modifies walking mechanics to influence postprandial glucose responses.
Human trials, Device, type 2 diabetes
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals3
- Integrity notices5
- Similar companies6
Papers
Journal of Yeungnam medical science, 10 Aug 2026
Assessing Advanced Glycation Endproducts Using a Wearable Health Monitoring Device
ADA Scientific Sessions 2026 abstract, 6 Jun 2026